Figure 1:

A pragmatic approach of oral anticoagulation for older people ≥75 years old with NVAF. All should be considered for oral anticoagulation if no contraindications. Periodic reassessment is recommended for further eligibility, and vice versa, of non eligible patients if their modified risk of bleeding e g uncontrolled hypertension is treated.